Precigen Earnings Estimates, EPS & Revenue | NASDAQ:PGEN

Comments

Precigen Inc Earnings Estimates

PGENNASDAQ

Trade with Public

$3.25

-0.42-11.44%

At close: Mar 27, 5:00 PM EST

$3.21

-0.46-12.53%

Pre-Market: 7:07 AM EST

Earnings: Q4 2025 Earnings were released on Wed Mar 25th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 6 days ago

Click to view the webcast

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Precigen Earnings Estimates, EPS & Revenue | NASDAQ:PGEN

Precigen (PGEN) is scheduled to report Q1 earnings on May 13, 2026. Analysts estimate EPS of $-0.07 and quarterly revenue of $17.84M.

In the most recent quarter (Q4), Precigen reported EPS of $-0.01, beating estimates of $-0.09 by 0.89%. Revenue came in at $4.57M, missing the estimate of $7.18M by 0.36%.

Over the last 4 quarters, Precigen has averaged an EPS surprise of 3.23% and a revenue surprise of 1.75%.

Earnings Date

May 13

EPS Estimate

$-0.070

Quarterly Revenue Estimate

$17.84M

Annual Revenue
(as of Dec 31)

$9.68M

Precigen Earnings History

Analyze the earnings history of Precigen using advanced sorting and filters.

Loading calendar...

Precigen (PGEN) Earnings Per Share

The chart below shows Precigen's reported EPS compared to analyst estimates over recent quarters.

Precigen (PGEN) Revenue

The chart below shows Precigen's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Precigen (NASDAQ:PGEN) reporting earnings?

Precigen (PGEN) is scheduled to report earnings on May 13, 2026. The last reported earnings were for reported on March 25, 2026 for Q4.

What were the latest earnings per share (EPS) for Precigen (NASDAQ:PGEN)?

The Actual EPS was $-0.01, which beat the estimate of $-0.09.

What were Precigen’s (NASDAQ:PGEN) revenues?

The Actual Revenue was $4.57M, which missed the estimate of $7.18M.

People Also Watch

CytomX Therapeutics Inc

NASDAQ:CTMX

$4.41

-0.07%

KalVista Pharmaceuticals Inc

NASDAQ:KALV

$18.31

-0.27%

MoonLake Immunotherapeutics

Monte Rosa Therapeutics Inc

NASDAQ:GLUE

$15.65

0.77%

Olema Pharmaceuticals inc

Precigen Earnings Estimates, EPS & Revenue | NASDAQ:PGEN

Precigen (PGEN) is scheduled to report Q1 earnings on May 13, 2026. Analysts estimate EPS of $-0.07 and quarterly revenue of $17.84M.

In the most recent quarter (Q4), Precigen reported EPS of $-0.01, beating estimates of $-0.09 by 0.89%. Revenue came in at $4.57M, missing the estimate of $7.18M by 0.36%.

Over the last 4 quarters, Precigen has averaged an EPS surprise of 3.23% and a revenue surprise of 1.75%.

Earnings Date

May 13

EPS Estimate

$-0.070

Quarterly Revenue Estimate

$17.84M

Annual Revenue
(as of Dec 31)

$9.68M